Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Navantia Leverages RTI Connext as the Foundational Infrastructure for Its Naval Operations
-
Omegro Expands its Presence in the Hospitality Vertical with Acquisition of ResRequest
-
AIBotics, Inc. Issues Mid-Year Shareholder Update Highlighting Corporate Progress, Technology Development, and Strategic Roadmap for Agentic AI Integration
-
Ecocem Achieves ASTM C1157 Certification, Signaling U.S. Market Readiness for Breakthrough Low-Carbon Cement
-
57 Confluent Health Physical and Occupational Therapists Receive Board-Certified Clinical Specialist Credential
-
Windfall Bio’s FOUNDATION Fertilizer Earns OMRI Listing for Use in Organic Farming
-
GreyOrange Teams With Google Cloud on Breakthrough Warehouse AI
-
Grace Therapeutics Announces First Quarter 2026 Financial Results, Provides Business Update
-
electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga
-
LEEF Brands Increases Private Placement to CAD $1.9 Million
-
Tryst Hospitality and The Elizabeth Taylor AIDS Foundation Expand Partnership with Launch of The Elizabeth Taylor Chocolate Martini
-
Integral Metals Provides Update on 2025 Drilling at the KAP Project
-
Core Molding Technologies to Present and Host 1x1 Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 26, 2025
-
Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
-
Ike’s Love & Sandwiches Opens Near Sac State, Serving Up Arden’s Newest Flavor Crush
-
NFI releases its Sustainability Report for 2024
-
Quantic Electronics to Exhibit at the 2025 SENEDIA Defense Innovation Days
-
UPONLY Launches Beta Testing Phase – $25,000 Bug Bounty, 30,000+ Users In, 1,000 USDC Test Credits Per Account!
-
Genius Group Seeks Dual Listing in Asia
-
AgEagle Aerial Systems Announces New RedEdge-P Green Camera to Advance Precision Agriculture
-
ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
-
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available
-
OptimumBank Holdings, Inc., Issues Second Quarter Earnings Transcript and Clarification on Projected Asset Growth
-
Nanox Announces Second Quarter of 2025 Financial Results and Provides Business Update
-
VPG to Present at Upcoming Investor Conferences on August 27, 2025, in Chicago, IL and September 3, 2025, in New York, NY
-
Hydreight Posts Record VSDHOne Growth, Ahead of 2025 Targets
-
Hirevue Launches Talent Engagement Agent to Solve the Hiring Speed vs. Quality Trade-off
-
iHerb Names Zach Thomann Chief Operating Officer to Power Global Growth and Fulfillment Innovation
-
Upexi Establishes Advisory Committee and Welcomes Arthur Hayes as First Member
-
CBAK Energy to Report Second Quarter 2025 Unaudited Financial Results on Monday, August 18, 2025
-
Bitcoin Depot Reports Second Quarter 2025 Financial Results
-
Newton Golf Company to Host Q2 2025 Earnings Call and Investor Q&A on August 14
-
Nuvini Group Expands Strategic AI Initiative with Launch of NuviniAI Prize, Driving Innovation and Investment Across Brazil’s B2B Software Sector
-
TransUnion Finds Auto Insurance Shopping Peaked in March and Remained Elevated Throughout Q2 2025
-
Cerevance to Participate in Piper Sandler Virtual CNS Symposium
-
Anteriad Celebrates Four-Year Streak on Inc. 5000’s Fastest-Growing Companies List
-
Eco Material Technologies Releases 2024 Sustainability Report Highlighting Advancements in U.S. Cement and Concrete Decarbonization
-
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Di
-
AssetMark Expands Advisor Capabilities with Enhanced Self-Directed Brokerage Account (SDBA) Solution
-
Abacus Global Management and Dynasty Financial Partners Announce Minority Investment
-
Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update
-
Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments
-
American Oncology Network Reports Strong Growth and Record Milestones in 2025
-
Counslr Launches in Schools Across the Country to Increase Mental Health Care Access
-
Hour Loop Reports Second Quarter of 2025 Results
-
PalCare Names Healthcare Veteran Lauren Wilson as Chief Revenue Officer to Lead Strategic Expansion
-
PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer
-
Elicio Therapeutics Announces Publication of ELI-002 Updated AMPLIFY-201 Phase 1 Follow-up Data in Nature Medicine for Minimal Residual Disease (“MRD”) Positive, Adjuvant-Stage Patients
-
MuniFin Group’s Pillar III Half Year Disclosure Report 2025 is published
-
Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
